These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2689091)

  • 1. Mechanism of insulin secretion and its modulation by sulfonylureas.
    Panten U
    Contrib Nephrol; 1989; 73():16-21; discussion 22-3. PubMed ID: 2689091
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview.
    Beck-Nielsen H; Hother-Nielsen O; Pedersen O
    Diabet Med; 1988 Oct; 5(7):613-20. PubMed ID: 2975544
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin release form isolated, human islets after acute or prolonged exposure to glimepiride.
    Del Guerra S; Parentini C; Bracci C; Lupi R; Marselli L; Aragona M; Navalesi R; Marchetti P
    Acta Diabetol; 2000; 37(3):139-41. PubMed ID: 11277315
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of sulfonylureas on calcium uptake and insulin secretion by islets of Langerhans.
    Malaisse WJ; Mahy M; Malaisse-Lagae F
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):205-7. PubMed ID: 4937349
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
    Laube H; Fussgänger RD; Schröder KE; Pfeiffer EF
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624
    [No Abstract]   [Full Text] [Related]  

  • 7. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of sulfonylurea stimulation of insulin release.
    Hellman B
    Acta Biol Med Ger; 1982; 41(12):1211-9. PubMed ID: 6765162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
    Loubatières AL; Ribes G; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV; Gladkikh AI
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets.
    Kawazu S; Sener A; Couturier E; Malaisse WJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):277-83. PubMed ID: 6995864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs.
    Horie M; Ishida-Takahashi A; Ai T; Nishimoto T; Tsuura Y; Ishida H; Seino Y; Sasayama S
    Cardiovasc Res; 1997 Apr; 34(1):69-72. PubMed ID: 9217874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular loci of sulfonylurea actions.
    Lebovitz HE
    Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part I--"The pros".
    Waldhäusl W
    Horm Metab Res; 1996 Sep; 28(9):517-21. PubMed ID: 8911990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mode of action of oral hypoglycemic sulfonylureas].
    Paes E
    Rev Iber Endocrinol; 1972; 19(113):449-59. PubMed ID: 4563178
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on new sulfonylurea derivatives and their metabolites in isolated Langerhans's islets of the rat pancreas (author's transl].
    Krause U; Puchinger H; Wacker A
    Arzneimittelforschung; 1975 Aug; 25(8):1231-3. PubMed ID: 810148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on kinetics of insulin secretion in perifused pancreatic islets of hamster. II. An inhibitory effect of sulfonylureas on a subsequent glucose-stimulated insulin secretion].
    Kikuchi M
    Fukuoka Igaku Zasshi; 1987 Feb; 78(2):46-54. PubMed ID: 3556363
    [No Abstract]   [Full Text] [Related]  

  • 19. Optical control of insulin release using a photoswitchable sulfonylurea.
    Broichhagen J; Schönberger M; Cork SC; Frank JA; Marchetti P; Bugliani M; Shapiro AM; Trapp S; Rutter GA; Hodson DJ; Trauner D
    Nat Commun; 2014 Oct; 5():5116. PubMed ID: 25311795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structure and action mechanism of sulfonylurea].
    Tasaka Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():333-8. PubMed ID: 12387014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.